Dear healthcare Community: Women’s Health and Psychedelic Medicine Can’t Wait

Written By Stephanie Karzon

This open letter was originally published in DoubleBlind Magazine's The Drop In newsletter on June 3, 2026. Read the original here.


Your female clients and patients are navigating psychedelic medicines across every life stage, with or without your clinical guidance. The time to get informed is now.

Stephanie Karzon Abrams, Clinical Pharmacology | Founder, Beyond Consulting & GALILEA Health

To care for women is not only to work within what is known, but to stay in relationship with what is unfolding.

We are in a moment of flux, and women are no longer waiting. They are taking their health into their own hands, reading their own labs, and asking harder questions. They are paying top dollar for therapies their primary care will not offer and their insurance plans won’t cover. They are expecting more from their providers, their medicines, and the system itself. 

They are also taking psychedelics. 

Keep reading HERE

Explore GALILEA: The Community

Stephanie Karzon
Next

You'll Probably Be Back: What MDD and TRD Patients Should Really Expect from Psychedelic Therapy and How Care Providers Should Be Talking About It